Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Pathology Informatics
|
January 7, 2014
Inter-reader variability in follicular lymphoma grading: Conventional and digital reading
Gerard Lozanski, Michael Pennell, Arwa Shana'ah, et al.
Seminars in Oncology
|
February 1, 2012
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies
Yogen Saunthararajah, Pierre Triozzi, Brian Rini, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Blood
|
January 25, 2011
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
Samar Farha, Kewal Asosingh, Weiling Xu, et al.
Blood
|
February 25, 2011
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima, Anna M Jankowska, Michael A McDevitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies
Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
The Lancet. Haematology
|
March 19, 2017
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials
Sonali M Smith, Brandelyn N Pitcher, Sin-Ho Jung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 7, 2018
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria
Elizabeth Margolskee, Geoff Mikita, Bryan Rea, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Pathology Informatics
|
January 7, 2014
Inter-reader variability in follicular lymphoma grading: Conventional and digital reading
Gerard Lozanski, Michael Pennell, Arwa Shana'ah, et al.
Seminars in Oncology
|
February 1, 2012
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies
Yogen Saunthararajah, Pierre Triozzi, Brian Rini, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Blood
|
January 25, 2011
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
Samar Farha, Kewal Asosingh, Weiling Xu, et al.
Blood
|
February 25, 2011
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima, Anna M Jankowska, Michael A McDevitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies
Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, et al.
The Lancet. Haematology
|
March 19, 2017
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials
Sonali M Smith, Brandelyn N Pitcher, Sin-Ho Jung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 7, 2018
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria
Elizabeth Margolskee, Geoff Mikita, Bryan Rea, et al.
Page
of 4